1Dell D D.Deep vein thrombosis in the patient with cancer[J].Clin J Oncol Nurs,2002,6(1):43-46.
2Sutherland D E,Weitz I C,Liebman H A.Thromboembolic complications of cancer:epidemiology,pathogenesis,diagnosis,and treatment[J].Am J Hematol,2003,72(1):43-52.
3Luxembourg B,Bauersachs R.Malignancy and thrombosis:a double-sided clinical relationship[J].Vasa,2005,34 (4):225 -234.
5Thodiyil P A,Kakkar A K.Variation in relative risk of venous thromboembolism in different cancers[J].Thromb Haemost,2002,87(6):1076-1077.
6Rosovsky R P,Kuter D J.Catheter-related thrombosis in cancer patients:pathophysiology,diagnosis,and management[J].Hematol Oncol Clin North Am,2005,19(1):183-202.
7Falanga A,Tickles F R.Pathophysiology of the thrombophilic state in the cancer patient[J].Semin Thromb Hemost,1999,25(2):173-182.
8Shoji M,Hancock W W,Abe K,et al.Activation of coagulation and angiogenesis in cancer:immunohistochemical localization in situ of clotting proteins and vascu-lar endothelial growth factor in humancancer[J].AmJPathol,1998,152(2):399-411.
9Bromberg M E,Cappello M.Cancer and blood coagulation:molecular aspects[J].Cancer J Sci Am,1999,5(3):132-138.
10Kakkar A K.Low molecular-weight heparins:beyond thrombosis in the management of the cancer patient[J].Semin Thromb Hemost,2003,29(Suppl 1):13-15.